Press release
Gastric Motility Disorder Drugs Market is Driven by Increasing Prevalence of Gastrointestinal Conditions By 2025-2033 | Pfizer Inc., Eisai Co., Ltd., Mallinckrodt, Salvus Pharma
Gastric Motility Disorder Drugs Market
The latest Gastric Motility Disorder Drugs Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/gastric-motility-disorder-drugs-market?ophp
These drugs treat conditions that slow digestion, such as gastroparesis, and help relieve symptoms like nausea or bloating. The market is growing with more cases of diabetes and GI disorders, especially in North America and expanding in Asia.
Gastric Motility Disorder Drugs Market Competitors Overview:
Pfizer Inc., Eisai Co., Ltd., Mallinckrodt, Salvus Pharma, Atmo Biosciences, AdvaCare Pharma, Avenacy, VAIKUNTH CHEMICALS PVT. LTD., Healthy Inc and Bhumi Pharmaceuticals among others.
Important Industry Updates of 2024 and 2025:
✅ In March 2024, Renexxion Ireland Limited announced that the U.S. Food and Drug Administration (FDA) has granted clearance for their Investigational New Drug (IND) application for naronapride. This drug is intended to treat patients suffering from gastroparesis, a condition characterized by delayed gastric emptying.
✅ In September 2023, Aclipse Therapeutics and its subsidiary, Aclipse Two, Inc., announced the signing of an exclusive licensing agreement with Chong Kun Dang Pharmaceutical Corporation (CKD), based in Seoul, South Korea. This agreement grants Aclipse the worldwide rights (excluding South Korea, Indonesia, and Vietnam) to develop CKD's lobeglitazone for the treatment of gastroparesis and other potential indications.
Gastric Motility Disorder Drugs Market Segments Overview:
∎ By Drug Type (Parasympathomimetics, Prokinetic Agents, Opioid Antagonists, Antidiarrheals, Anti-Emetic Drugs, Antibiotics, Others)
∎ By Disorder Type (Achalasia, Esophageal spasms, Heartburn, or Gastroesophageal Reflux Disease (GERD), Gastroparesis, Irritable Bowel Syndrome (IBS), Fecal incontinence, Intestinal Pseudo-obstruction, Others)
∎ By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/gastric-motility-disorder-drugs-market?ophp
Methodology and Scope:
This Gastric Motility Disorder Drugs Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.
Regional Overview for Gastric Motility Disorder Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=gastric-motility-disorder-drugs-market?ophp
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➤ What are the global sales, production, import, and export trends in the Gastric Motility Disorder Drugs market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Gastric Motility Disorder Drugs market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Motility Disorder Drugs Market is Driven by Increasing Prevalence of Gastrointestinal Conditions By 2025-2033 | Pfizer Inc., Eisai Co., Ltd., Mallinckrodt, Salvus Pharma here
News-ID: 4096022 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Liquid Hydrogen Market valuation $65.9 billion by 2032 - Exclusive …
"The global liquid hydrogen market was valued at US$ 42.3 billion in 2024 and is projected to reach US$ 65.9 billion by 2032, growing at a CAGR of 5.7% during the forecast period 2025-2032." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/liquid-nitrogen-market?sp
United States: Recent Industry Developments
✅ In September 2025, Air Products & Chemicals launched a large-scale liquid hydrogen production facility in…
United States Collateral Ligament Stabilizer System Market 2025 | Growth Drivers …
Market Size and Growth
The Global Collateral Ligament Stabilizer System Market reached US$2.32 Billion in 2024 and is expected to reach US$4.11 Billion by 2033, growing at a CAGR of 6.5% during the forecast period 2025-2033, according to DataM Intelligence report.
Recent Mergers and acquisitions:
United States: Recent M&A and Investment Developments
✅ In March 2025, Stryker Corporation announced the acquisition of OrthoFix Holdings, a leading provider of orthopedic solutions. This strategic move…
United States Diagnostic Imaging Market valuation $46.25 billion by 2033 - Exclu …
"The global diagnostic imaging market reached US$ 29.93 billion in 2024 and is expected to reach US$ 46.25 billion by 2033, growing at a CAGR of 4.9% during the forecast period of 2025-2033." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/diagnostic-imaging-market?sp
United States: Recent Industry Developments
✅ In September 2025, GE Healthcare launched a next-generation diagnostic imaging platform combining AI-assisted CT, MRI, and…
United States AI in Medical Imaging Market valuation $11.25 billion by 2033 - Ex …
"The global AI in medical imaging market was valued at US$ 1.29 Billion in 2023. The market size reached US$ 1.58 Billion in 2024 and is expected to reach US$ 11.25 Billion by 2033, growing at a CAGR of 24.6% during the forecast period 2025-2033." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/ai-in-medical-imaging-market?sp
United States: Recent Industry Developments
✅ In September 2025, Siemens…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
